FOLLOW US

  • facebook
  • twitter
Fri

March 20, 2026

Eikon's Upsized $381M IPO

America February 5, 2026

Eikon’s Upsized $381M IPO Ignites Nasdaq Debut

Oncology-focused biopharmaceutical firm Eikon Therapeutics stepped onto the public stage Thursday, as Eikon’s Upsized $381M IPO powered its Nasdaq debut…

By Rachel Moore

Novartis Buy Avidity Biosciences

America October 27, 2025

Novartis to Buy Avidity Biosciences in $12 Billion Deal

In a bold step that cements its place at the forefront of genetic medicine, Novartis AG announced Sunday that it…

By Rihem Akkouche

BioCryst to acquire Astria

America October 14, 2025

BioCryst to Acquire Astria in $700M Deal

In a bold move that strengthens its foothold in the rare disease and immunology market, BioCryst Pharmaceuticals Inc. announced Tuesday…

By Rihem Akkouche

Draig Therapeutics $140M Financing

America June 18, 2025

Draig Therapeutics Secures $140M Series A

Draig Therapeutics Ltd., a rising star in neuropsychiatric drug development, has closed a $140 million Series A financing round, the…

By Rihem Akkouche

Eaton to acquire Ultra PCS

America June 16, 2025

Eaton to Acquire Ultra PCS in $1.55B Deal

In a strategic leap that fuses power with precision, Eaton Corp., the global power management titan, announced Monday it will…

By Rihem Akkouche

AbbVie Buys Celsius For $250M

America June 27, 2024

AbbVie Buys Celsius Therapeutics For $250M

Chicago-based pharmaceutical company AbbVie announced Thursday its acquisition of Celsius Therapeutics Inc., a privately held clinical-stage biotechnology firm focused on…

By Rihem Akkouche

Signup for the USA Herald
exclusive Newsletter